DSpace at RU >

Browsing by Author Griffiths, C.E.

Full Text	Issue Date	Title	Author(s)
	2012	Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.	Tsoi, L.C.; Spain, S.L.; Knight, J.; Ellinghaus, E.; Stuart, P.E., et al
	2011	Improving clinical trial design in psoriasis: Perspectives from the global dermatology community.	Kerkhof, P.C.M. van de; Barker, J.; Griffiths, C.E.; Menter, A.; Leonardi, C., et al
	2010	A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.	Strange, A.; Capon, F.; Spencer, C.C.; Knight, J.; Weale, M.E., et al
	2010	Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.	Griffiths, C.E.; Strober, B.E.; Kerkhof, P.C.M. van de; Ho, V.; Fidelus-Gort, R., et al
	2008	Psoriasis: consensus on topical therapies.	Kerkhof, P.C.M. van de; Barker, J.; Griffiths, C.E.; Kragballe, K.; Mason, J., et al
	2006	The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.	Christophers, E.; Griffiths, C.E.; Gaitanis, G.; Kerkhof, P.C.M. van de
	2005	Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.	Kerkhof, P.C.M. van de; Griffiths, C.E.; Christophers, E.; Lebwohl, M.G.; Krueger, G.G.
	2005	A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.	Papp, K.A.; Tyring, S.; Lahfa, M.; Prinz, J.C.; Griffiths, C.E., et al
	2004	Biological therapies in the systemic management of psoriasis : International Consensus Conference	Sterry, W.; Barker, J.; Boehncke, W.H.; Bos, J.D.; Chimenti, S., et al